Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2012 2
2013 11
2014 100
2015 105
2016 73
2017 79
2018 93
2019 111
2020 110
2021 116
2022 125
2023 176
2024 128
2025 89

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,104 results

Results by year

Filters applied: . Clear all
Page 1
Comparison of Contemporary Radiation Therapy Approaches in Combined Modality Treatment on Pediatric High-Risk Classic Hodgkin Lymphoma Study: AHOD 1331.
Hoppe BS, Mailhot-Vega RB, Renfro LA, Pei Q, Charpentier AM, Parikh RR, Roberts KB, Keller FG, Punnett A, Parsons S, Voss SD, Alzaraki A, McCarten KM, Flampouri S, Kessel S, Wu Y, Cho SY, Kelly KM, Castellino SM, Hodgson DC. Hoppe BS, et al. Int J Radiat Oncol Biol Phys. 2025 Nov 15;123(4):972-979. doi: 10.1016/j.ijrobp.2025.06.3876. Epub 2025 Jun 28. Int J Radiat Oncol Biol Phys. 2025. PMID: 40588069
Updated favourable-histology Wilms tumour risk stratification: rationale for future Children's Oncology Group clinical trials.
Benedetti DJ, Cost NG, Ehrlich PF, Evageliou N, Fialkowski E, Parsons LN, Vallance KL, Renfro LA, Hong AL, Aldrink JH, Pater L, Paulino AC, Sandberg JK, Smith EA, Treece AL, Dome JS, Geller JI, Mullen EA. Benedetti DJ, et al. Nat Rev Urol. 2025 Nov;22(11):775-788. doi: 10.1038/s41585-025-01055-1. Epub 2025 Jun 20. Nat Rev Urol. 2025. PMID: 40542227 Review.
Genome-wide association study of childhood B-cell acute lymphoblastic leukemia reveals novel African ancestry-specific susceptibility loci.
Im C, Raduski AR, Mills LJ, Bhattarai KR, Mobley RJ, Barnett KR, Lu Z, Liao K, Anderson N, Johnson RA, Langer E, Hooten AJ, Seif AE, Bernt KM, Tsang M, Mamou BA, Gil-de-Gómez L, Wolfson JA, Friedman DN, Shukla N, Klesse LJ, Marcotte EL, Ji L, Dang A, Luo M, Zhong Y, Langie J, Chiang CWK, de Smith A, Wiemels JL, DeWan A, Ma X, Metayer C, Wang Z, Nelson HH, Pankratz N, Yang T, Basu S, Turcotte LM, Yang JJ, Savic D, Scheurer ME, Spector LG. Im C, et al. Nat Commun. 2025 Oct 22;16(1):8974. doi: 10.1038/s41467-025-64337-7. Nat Commun. 2025. PMID: 41125582 Free PMC article.
Germline Pathogenic/Likely Pathogenic Mutations and Subsequent Neoplasms Among Childhood Cancer Survivors: A Report From the Children's Oncology Group ALTE03N1 Study.
Zhou L, Singh P, Crossman D, Richman J, Trainor P, Cheng C, Wang X, Sharafeldin N, Hageman L, Sheikh M, Richard MA, Friedman DN, Neglia JP, Wang Z, Hudson MM, Armenian SH, Hawkins D, Bhatia R, Landier W, Bhatia S. Zhou L, et al. J Clin Oncol. 2025 Sep 20;43(27):3011-3020. doi: 10.1200/JCO-25-00542. Epub 2025 Aug 19. J Clin Oncol. 2025. PMID: 40829087 Free PMC article.
EZH2-driven immune evasion at disease presentation defines a targetable high-risk subset of acute leukemia exemplified by t(16;21) FUS::ERG AML.
Buteyn NJ, LaMantia SJ, Burke CG, Sartori VJ, Deering-Gardner E, DeBruine ZJ, Kamarudin D, Chandler DP, Monovich AC, Perez MW, Yi JS, Ries RE, Alonzo TA, Ryan RJ, Meshinchi S, Triche TJ Jr. Buteyn NJ, et al. bioRxiv [Preprint]. 2025 Sep 18:2024.05.14.594150. doi: 10.1101/2024.05.14.594150. bioRxiv. 2025. PMID: 38798454 Free PMC article. Preprint.
Enrollment in Children's Oncology Group's clinical trials: population-based linkage with the National Childhood Cancer Registry.
Lupo PJ, Siegel DA, Schussler NC, Alonzo TA, Adams S, Angelaszek D, Basavappa S, Chambers TM, Coyle L, Durbin E, Goderre JL, Hayes T, Howe W, Hsu E, Lee R, Lewis DR, Mariotto AB, Pollock BH, Preda A, Roth ME, Stevens J, Terranova T, Vargas SL, Hawkins DS, Penberthy L. Lupo PJ, et al. J Natl Cancer Inst. 2025 Sep 1;117(9):1868-1874. doi: 10.1093/jnci/djaf134. J Natl Cancer Inst. 2025. PMID: 40515409
Radiation Therapy Dose Escalation Failed to Improve Local Control for Intermediate-Risk Rhabdomyosarcoma on ARST1431: A Report From the Children's Oncology Group.
Jackson CB, Xue W, Gupta AA, Qumseya A, Dasgupta R, Hill-Kayser CE, Spalding AC, Rodeberg DA, Harrison DJ, Venkatramani R, Wolden SL. Jackson CB, et al. Int J Radiat Oncol Biol Phys. 2025 Sep 1;123(1):54-62. doi: 10.1016/j.ijrobp.2025.03.038. Epub 2025 Apr 2. Int J Radiat Oncol Biol Phys. 2025. PMID: 40185209 Clinical Trial.
Prioritization of novel agents for further investigation in pediatric non-rhabdomyosarcoma soft tissue sarcomas: A report from the Children's Oncology Group.
Crane JN, Douglass DP, Oberoi S, Collins NB, Gupta A, Metts JL, Avutu V, Dela Cruz FS, Davis JL, Federman NC, Hiniker SM, Laetsch TW, Linardic CM, Navid F, Saab R, Shulman DS, Shern JF, Soragni A, Stewart EA, Terezakis S, Weigel BJ, Weiss AR. Crane JN, et al. Eur J Cancer. 2025 Aug 26;226:115600. doi: 10.1016/j.ejca.2025.115600. Epub 2025 Jul 6. Eur J Cancer. 2025. PMID: 40651390 Review.
Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia.
Newman H, Lee SHR, Pölönen P, Shraim R, Li Y, Liu H, Aplenc R, Bandyopadhyay S, Chen C, Devidas M, Diorio C, Dunsmore K, Elghawy O, Elhachimi A, Fuller T, Gupta S, Hall J, Hughes AD, Hunger SP, Loh ML, Martinez Z, McCoy MF, Mullen CG, Pounds SB, Raetz E, Seffernick AE, Shi G, Sussman J, Tan K, Uppuluri L, Vincent TL, Wang'ondu R, Winestone LE, Winter SS, Wood BL, Wu G, Xu J, Yang W, Mullighan CG, Yang JJ, Bona K, Teachey DT. Newman H, et al. Blood Cancer Discov. 2025 Aug 8:OF1-OF13. doi: 10.1158/2643-3230.BCD-25-0049. Online ahead of print. Blood Cancer Discov. 2025. PMID: 40778665
Childhood Cancer Data Initiative: Expanded access to tumor molecular profiling for children, adolescents, and young adults.
Flores-Toro J, Jagu S, Smith M, Shern J, Hawkins DS, Mardis ER, Rudzinski E, Alonzo TA, Beeles T, Ramirez N, Thomas DL, Cottrell CE, Parbhoo K, Janeway KA, Leary S, Fouladi M, Oberoi S, Venkatramani R, Irwin M, Laetsch TW, Chen KS, Bailey K, Davis JL, Sullivan MB, Boja E, Lowy D, Guidry Auvil JM, Wideman B, Kibbe W, Doroshow J, Reaman GH. Flores-Toro J, et al. J Natl Cancer Inst. 2025 Aug 6:djaf214. doi: 10.1093/jnci/djaf214. Online ahead of print. J Natl Cancer Inst. 2025. PMID: 40794906 Free PMC article.
Preoperative Radiotherapy in Patients With Localized Ewing Sarcoma Enrolled on AEWS1031: A Report From the Children's Oncology Group.
Indelicato DJ, Callan AK, Ahmed SK, Krailo M, DelRocco N, Buxton AB, Binitie OT, Christ AB, Kessell S, Chuba PJ, Nadel HR, Pawel BR, Gorlick R, Reed DR, DuBois SG, Janeway KA, Leavey P, Mascarenhas L, Laack NN. Indelicato DJ, et al. Pediatr Blood Cancer. 2025 Aug;72(8):e31820. doi: 10.1002/pbc.31820. Epub 2025 May 25. Pediatr Blood Cancer. 2025. PMID: 40415235
Remaining Challenges in the Treatment of Relapsed Wilms Tumor: Children's Oncology Group and International Society of Paediatric Oncology Perspectives.
Sutton KS, Walz AL, Groenendijk A, Murphy AJ, Pater L, Janssens GO, Brzezinski J, Mullen EA, Spreafico F, Godzinski J, van der Beek J, Hwa Wijnen M, van den Heuvel-Eibrink MM, Pachl M, Graf N, Ehrlich PF, Furtwangler R, Brok J, Geller J. Sutton KS, et al. Pediatr Blood Cancer. 2025 Aug;72(8):e31790. doi: 10.1002/pbc.31790. Epub 2025 May 14. Pediatr Blood Cancer. 2025. PMID: 40369656
NAPRT expression and epigenetic regulation in pediatric rhabdomyosarcoma as a potential biomarker for NAMPT inhibition.
Kim A, Bhardwaj P, Heer CD, Zhao SJ, Lucas KN, Noronha KJ, Friedman S, Morotti R, Sundaram RK, Rehman S, Bhatt D, Cruz FSD, Feinberg TY, Ramakrishnan S, Xue W, Barkauskas DA, Hall D, Shern JF, Sun W, Barr FG, Yi JS, Spurrier J, Yu A, Brenner C, Heske CM, Vasquez JC. Kim A, et al. bioRxiv [Preprint]. 2025 Jul 31:2025.07.28.667284. doi: 10.1101/2025.07.28.667284. bioRxiv. 2025. PMID: 40766550 Free PMC article. Preprint.
Epigenomic diagnosis and prognosis of Acute Myeloid Leukemia.
Marchi F, Shastri VM, Marrero RJ, Nguyen NHK, Öttl A, Schade AK, Landwehr M, Krali O, Nordlund J, Ghavami M, Sckaff F, Mansinghka VK, Cao X, Slayton W, Starostik P, Cogle CR, Ribeiro RC, Rubnitz JE, Klco J, Elsayed A, Gamis AS, Triche TJ Jr, Ries R, Kolb EA, Aplenc R, Alonzo T, Pounds S, Meshinchi S, Lamba JK. Marchi F, et al. Nat Commun. 2025 Jul 29;16(1):6961. doi: 10.1038/s41467-025-62005-4. Nat Commun. 2025. PMID: 40730747 Free PMC article.
The impact of genetic ancestry on survival outcomes in pediatric rhabdomyosarcoma: A report from the Children's Oncology Group.
Onwuka EA, Magyar CL, Martin-Giacalone BA, Scheurer ME, Marquez-Do DA, Zobeck M, Atkinson EG, Rudzinski ER, Arnold MA, Barkauskas DA, Hall D, Khan J, Shern JF, Scheet P, Crompton B, Linardic CM, Hawkins DS, Venkatramani R, Mirabello L, Huff CD, Richard MA, Lupo PJ. Onwuka EA, et al. HGG Adv. 2025 Jul 10;6(3):100466. doi: 10.1016/j.xhgg.2025.100466. Epub 2025 Jun 9. HGG Adv. 2025. PMID: 40495382 Free PMC article.
Inferring chromosome segregation error stage and crossover in trisomic disorders with application to Down syndrome.
Li Z, Yang W, Wu G, Chang TC, Cheng Z, Devidas M, Shago M, Carroll AJ, Heerema NA, Gastier-Foster JM, Wood BL, Sanclemente L, Raetz EA, Hunger SP, Loh ML, Feingold E, Rosser TC, Allen EG, Sherman SL, Rabin KR, Lupo PJ, Yang JJ. Li Z, et al. Nat Commun. 2025 Jul 9;16(1):6316. doi: 10.1038/s41467-025-61413-w. Nat Commun. 2025. PMID: 40628699 Free PMC article.
Heterogeneity of IKZF1 genomic alterations and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia.
Wang'ondu RW, Ashcraft E, Chang TC, Roberts KG, Brady SW, Fan Y, Evans W, Relling MV, Crews KR, Yang J, Yang W, Pounds S, Wu G, Devidas M, Maloney K, Mattano L, Schore RJ, Angiolillo A, Larsen E, Salzer W, Burke MJ, Loh ML, Jeha S, Pui CH, Inaba H, Cheng C, Mullighan CG. Wang'ondu RW, et al. Leukemia. 2025 Jul;39(7):1595-1606. doi: 10.1038/s41375-025-02633-3. Epub 2025 May 13. Leukemia. 2025. PMID: 40360879
Severe toxicity and poor efficacy of reinduction chemotherapy are associated with overall poor outcomes in relapsed B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group AALL1331 trial.
Hogan LE, Bhatla T, Xu X, Gore L, Raetz EA, Bhojwani D, Teachey DT, Hunger SP, Loh ML, Brown PA, Ji L. Hogan LE, et al. Haematologica. 2025 Jun 26. doi: 10.3324/haematol.2025.287386. Online ahead of print. Haematologica. 2025. PMID: 40568722 Free article.
Hematopoietic Stem Cell Transplantation Outcomes for High-Risk AML: A Report From the Children's Oncology Group.
Huang BJ, Meyer LK, Alonzo TA, Wang YC, Lamble AJ, Ries RE, Wang W, Hirsch B, Raca G, Ma X, Gamis AS, Aplenc R, Kolb EA, Cooper TM, Tarlock K, Loken MR, Meshinchi S, Chewning JH, Woods WG, Horan JT. Huang BJ, et al. J Clin Oncol. 2025 Jun 10;43(17):1961-1971. doi: 10.1200/JCO-24-01841. Epub 2025 Apr 28. J Clin Oncol. 2025. PMID: 40294366 Free PMC article. Clinical Trial.
STAT1-mediated interferon signatures are associated with preclinical JAK inhibitor sensitivity in T-ALL.
Xu J, Sussman JH, Yang A, Yoshimura S, Hu J, Chen C, Vincent T, Bandyopadhyay S, Li EY, Lim T, Elghawy O, Barsouk A, Karanfilovski D, Wald SL, Chen GM, Wu D, Newman H, Li A, Sun Y, Chen CH, Bernt K, Wood BL, Winter SS, Dunsmore KP, Raetz E, Devidas M, Pounds S, Loh M, Hunger SP, Chiang MY, Diorio C, Di Giacomo D, Pölönen P, Mullighan CG, Yang JJ, Tan K, Teachey DT. Xu J, et al. Blood. 2025 Jun 5;145(23):2793-2798. doi: 10.1182/blood.2025028566. Blood. 2025. PMID: 40101143
Single-cell panleukemia signatures of HSPC-like blasts predict drug response and clinical outcome.
Chen C, Xu J, Sussman JH, Vincent T, Tumulty JS, Yoshimura S, Alikarami F, Yu W, Ding YY, Chen CH, Li EY, Yang A, Qin X, Bandyopadhyay S, Peng J, Pölönen P, Newman H, Wood BL, Hu J, Shraim R, Hughes AD, Diorio C, Uppuluri L, Shi G, Ryan T, Fuller T, Loh ML, Raetz EA, Hunger SP, Pounds SB, Mullighan CG, Frank D, Yang JJ, Bernt KM, Teachey DT, Tan K. Chen C, et al. Blood. 2025 Jun 5;145(23):2685-2700. doi: 10.1182/blood.2024027270. Blood. 2025. PMID: 40089994 Free PMC article.
Fertility Preservation Services for Adolescents and Young Adults: 2022 National Cancer Institute Community Oncology Research Program Landscape Assessment.
Mobley EM, Wolfson JA, Levine J, Ji L, Ramakrishnan S, Nightingale CL, Dressler EV, Kittel C, Freyer DR, Sugalski AJ, Prasad PK, Bhutada JS, Murphy K, Kyono W, Roth ME, Parsons SK, Beauchemin MP; Landscape Committee. Mobley EM, et al. JCO Oncol Pract. 2025 Jun 4:OP2401017. doi: 10.1200/OP-24-01017. Online ahead of print. JCO Oncol Pract. 2025. PMID: 40466034
Cytarabine Pharmacogenomics and Outcomes Among Children and Young Adults With Acute Myeloid Leukemia.
Marrero RJ, Shastri VM, Nicolet D, Mrózek K, Walker CJ, Blum WG, Powell BL, Kolitz JE, Moore JO, Uy GL, Stock W, Carroll AJ, Byrd JC, Aplenc R, Cooper TM, Gamis AS, Wu H, Pounds S, Wang YC, Alonzo TA, Meshinchi S, Eisfeld AK, Kolb EA, Lamba JK. Marrero RJ, et al. JAMA Netw Open. 2025 Jun 2;8(6):e2516296. doi: 10.1001/jamanetworkopen.2025.16296. JAMA Netw Open. 2025. PMID: 40549387 Free PMC article. Clinical Trial.
High immunoproteasome and low constitutive proteasome subunit levels correlate with sensitivity to bortezomib-containing chemotherapy: update from the Children's Oncology Group AALL1231 trial.
Roeten MSF, Van Meerloo J, Van Dijk SN, Kwidama Z, Jenkins G, Teachey DT, Devidas M, Loh ML, Kaspers GJL, Zweegman S, Jansen G, Horton TM, Cloos J. Roeten MSF, et al. Haematologica. 2025 Jun 1;110(6):1379-1383. doi: 10.3324/haematol.2024.286171. Epub 2025 Jan 30. Haematologica. 2025. PMID: 39882653 Free PMC article. No abstract available.
Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia.
Newman H, Lee SHR, Pölönen P, Shraim R, Li Y, Liu H, Aplenc R, Bandyopadhyay S, Chen C, Devidas M, Diorio C, Dunsmore K, Elghawy O, Elhachimi A, Fuller T, Gupta S, Hall J, Hughes AD, Hunger SP, Loh ML, Martinez Z, McCoy MF, Mullen CG, Pounds SB, Raetz E, Seffernick AE, Shi G, Sussman J, Tan K, Uppuluri L, Vincent TL, Wang'ondu R, Winestone LE, Winter SS, Wood BL, Wu G, Xu J, Yang W, Mullighan CG, Yang JJ, Bona K, Teachey DT. Newman H, et al. Blood Cancer Discov. 2025 May 28. doi: 10.1158/2643-3230.BCD-25-0049. Online ahead of print. Blood Cancer Discov. 2025. PMID: 40434808
Phase 2 trial of veliparib, local irradiation, and temozolomide in patients with newly diagnosed high-grade glioma: a Children's Oncology Group study.
Karajannis MA, Onar-Thomas A, Lin T, Baxter PA, Boué DR, Cole BL, Fuller C, Haque S, Jabado N, Lucas JT Jr, MacDonald SM, Matsushima C, Patel N, Pierson CR, Souweidane MM, Thomas DL, Walsh MF, Zaky W, Leary SES, Gajjar A, Fouladi M, Cohen KJ. Karajannis MA, et al. Neuro Oncol. 2025 May 15;27(4):1092-1101. doi: 10.1093/neuonc/noae247. Neuro Oncol. 2025. PMID: 39560182 Clinical Trial.
Frequency and Clinical Significance of Clonal and Subclonal Driver Mutations in High-Risk Neuroblastoma at Diagnosis: A Children's Oncology Group Study.
Berko ER, Naranjo A, Daniels AA, McNulty SN, Krytska K, Druley T, Zelley K, Koneru B, Chen L, Polkosnik G, Irwin MS, Bagatell R, Maris JM, Reynolds CP, DuBois SG, Park JR, Mossé YP. Berko ER, et al. J Clin Oncol. 2025 May 10;43(14):1673-1684. doi: 10.1200/JCO-24-02407. Epub 2025 Mar 4. J Clin Oncol. 2025. PMID: 40036726 Free PMC article. Clinical Trial.
Guideline-concordant treatment among adolescents and young adults with acute lymphoblastic leukemia.
Wolfson JA, Grimes AC, Nuño MM, Ramakrishnan S, Dickens DS, Roth ME, Woods W, Adams KS, Alabi T, Beauchemin M, Levine JM, Scialla M, Boayue KB, Kerber CL, Ponce O, Vargas S, Chang GJ, Stock W, Hershman D, Curran E, Advani A, O'Dwyer K, Luger S, Liu JJ, Freyer DR, Sung L, Parsons SK. Wolfson JA, et al. JNCI Cancer Spectr. 2025 Apr 30;9(3):pkaf033. doi: 10.1093/jncics/pkaf033. JNCI Cancer Spectr. 2025. PMID: 40238217 Free PMC article.
Associations of Patient Age, Tumor Nephrectomy Weight, and Tumor Diameter with Event-Free and Overall Survival in Stage I or II Favorable Histology Wilms Tumor: A Pooled Analysis of Children's Oncology Group Studies AREN0532 and AREN03B2.
Renfro LA, Vallance KL, Tfirn IC, Evageliou N, Benedetti DJ, Shamberger RC, Ehrlich PF, Cost NG, Aldrink JH, Schechter A, Treece A, Parsons LN, Walz AL, Sutton KS, Armstrong AE, Fernandez CV, Dome JS, Geller JI, Mullen EA; AREN03B2 Authorship Group. Renfro LA, et al. Ann Surg. 2025 Apr 11:10.1097/SLA.0000000000006726. doi: 10.1097/SLA.0000000000006726. Online ahead of print. Ann Surg. 2025. PMID: 40211953
DNA Damage Response and Repair Genes and Anthracycline-Induced Cardiomyopathy in Childhood Cancer Survivors: A Report From the Children's Oncology Group and the Childhood Cancer Survivor Study.
Wang X, Singh P, Cejas RB, Zhou L, Sharafeldin N, Trainor PJ, Landier W, Cheng C, Hageman L, Wang F, Sapkota Y, Yasui Y, Hudson MM, Chow EJ, Armenian SH, Neglia JP, Hawkins DS, Ginsberg JP, Burridge PW, Armstrong GT, Bhatia S. Wang X, et al. Circ Genom Precis Med. 2025 Apr;18(2):e004813. doi: 10.1161/CIRCGEN.124.004813. Epub 2025 Mar 28. Circ Genom Precis Med. 2025. PMID: 40151933
Lymph Node Staging and Treatment in Pediatric Patients With Soft Tissue Sarcomas: A Consensus Opinion From the Children's Oncology Group, European paediatric Soft Tissue Sarcoma Study Group, and the Cooperative Weichteilsarkom Studiengruppe.
Terwisscha van Scheltinga S, Schoot RA, Routh JC, Seitz G, Kao SC, de Keizer B, Shulkin B, Ewijk RV, McCarville B, Casey D, Allen-Rhoades W, Mercolini F, Merks H, Orbach D, Kapadia T, Walterhouse DO, Davila Fajardo R, Hiemcke-Jiwa L, Franzius C, De Corti F, Tang V, Metts J, Oberoi S, Vokuhl C, Dasgupta R, Birz S, Rodeberg D. Terwisscha van Scheltinga S, et al. Pediatr Blood Cancer. 2025 Apr;72(4):e31538. doi: 10.1002/pbc.31538. Epub 2025 Jan 23. Pediatr Blood Cancer. 2025. PMID: 39844722
Current surgical approaches to pediatric renal tumors.
Glick RD, Romao RLP, Pachl M, Kotagal M, Buchanan AF, Murphy AJ, Tracy ET, Pio L, Cost NG, Godzinski J, Ehrlich PF. Glick RD, et al. Pediatr Blood Cancer. 2025 Apr;72 Suppl 2(Suppl 2):e31118. doi: 10.1002/pbc.31118. Epub 2024 May 29. Pediatr Blood Cancer. 2025. PMID: 38809413 Review.
Evaluation and Surgical Management of Pediatric Cutaneous Melanoma and Atypical Spitz and Non-Spitz Melanocytic Tumors (Melanocytomas): A Report From Children's Oncology Group.
Sargen MR, Barnhill RL, Elder DE, Swetter SM, Prieto VG, Ko JS, Bahrami A, Gerami P, Karunamurthy A, Pappo AS, Schuchter LM, LeBoit PE, Yeh I, Kirkwood JM, Jen M, Dunkel IJ, Durham MM, Christison-Lagay ER, Austin MT, Aldrink JH, Mehrhoff C, Hawryluk EB, Chu EY, Busam KJ, Sondak V, Messina J, Puig S, Colebatch AJ, Coughlin CC, Berrebi KG, Laetsch TW, Mitchell SG, Seynnaeve B. Sargen MR, et al. J Clin Oncol. 2025 Mar 20;43(9):1157-1167. doi: 10.1200/JCO.24.01154. Epub 2024 Oct 4. J Clin Oncol. 2025. PMID: 39365959
DNTT-mediated DNA damage response drives inotuzumab ozogamicin resistance in B-cell acute lymphoblastic leukemia.
Escherich CS, Moriyama T, Li Z, Hsiao YC, Yang W, Li Y, Reyes N, Walker M, Budhraja A, Bhatara S, Diaz-Flores E, Stock W, Paietta E, Konopleva MY, Kornblau SM, Litzow MR, Inaba H, Pui CH, Opferman JT, Loh ML, Yu J, O'Brien MM, Evans WE, Yang JJ. Escherich CS, et al. Blood. 2025 Mar 13;145(11):1182-1194. doi: 10.1182/blood.2024026085. Blood. 2025. PMID: 39791601
Reply to: Accurate Determinants of Outcome in ALL.
Chang TC, Chen W, Qu C, Cheng Z, Elsayed A, Pounds SB, Shago M, Rabin KR, Raetz EA, Devidas M, Cheng C, Angiolillo A, Baviskar P, Borowitz M, Burke MJ, Carroll A, Carroll WL, Chen IM, Harvey R, Heerema N, Iacobucci I, Wang JR, Jeha S, Larsen E, Mattano L, Maloney K, Pui CH, Ramirez NC, Salzer W, Willman C, Winick N, Wood B, Hunger SP, Wu G, Mullighan CG, Loh ML. Chang TC, et al. J Clin Oncol. 2025 Mar 10;43(8):1039-1041. doi: 10.1200/JCO-24-02335. Epub 2024 Dec 23. J Clin Oncol. 2025. PMID: 39715469 No abstract available.
Influence of Nucleophosmin (NPM1) Genotypes on Outcome of Patients With AML: An AIEOP-BFM and COG-SWOG Intergroup Collaboration.
Tregnago C, Benetton M, Ries RE, Peplinski JH, Alonzo TA, Stirewalt D, Othus M, Duployez N, Sonneveld E, Abrahamsson J, Fogelstrand L, von Neuhoff N, Hasle H, Reinhardt D, Meshinchi S, Locatelli F, Pigazzi M. Tregnago C, et al. J Clin Oncol. 2025 Mar 10;43(8):972-984. doi: 10.1200/JCO-24-01715. Epub 2024 Dec 2. J Clin Oncol. 2025. PMID: 39621969
Prevention and Management of Infectious Complications in Pediatric Patients With Cancer: A Survey Assessment of Current Practices Across Children's Oncology Group Institutions.
Slatnick LR, Hoogstra D, Fisher BT, Wolf J, Orgel E, Nessle CN, Patel PA, Miller TP, Wilkes J, Dupuis LL, Goode E, Jackson K, Willis DN, Elgarten C, Aftandilian C, Thompson J, Alexander S, Beauchemin MP, Belsky JA, Hess J, Prudowsky ZD, Guinipero T, Rossoff J, Demedis J, Walsh AM, Richards R, Choi DK, Dvorak CC, Esbenshade AJ. Slatnick LR, et al. Pediatr Blood Cancer. 2025 Mar;72(3):e31532. doi: 10.1002/pbc.31532. Epub 2025 Jan 8. Pediatr Blood Cancer. 2025. PMID: 39780366
Rhabdoid Tumor of the Kidney and Soft Tissues: Results from National Wilms Tumor Study-5 and Children's Oncology Group Study AREN0321.
Geller JI, Renfro LA, Grundy PE, Perlman EJ, Kalapurakal JA, Ehrlich PF, Biegel J, Huff V, Warwick AB, Paulino A, Mullen EA, Daw NC, Hoffer FA, Tochner Z, Gow K, Gratias E, Ward DA, Anderson JR, Fernandez CV, Dome JS. Geller JI, et al. Pediatr Blood Cancer. 2025 Mar;72(3):e31490. doi: 10.1002/pbc.31490. Epub 2024 Dec 19. Pediatr Blood Cancer. 2025. PMID: 39702900
Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children.
Gupta S, Rau RE, Kairalla JA, Rabin KR, Wang C, Angiolillo AL, Alexander S, Carroll AJ, Conway S, Gore L, Kirsch I, Kubaney HR, Li AM, McNeer JL, Militano O, Miller TP, Moyer Y, O'Brien MM, Okada M, Reshmi SC, Shago M, Wagner E, Winick N, Wood BL, Haworth-Wright T, Zaman F, Zugmaier G, Zupanec S, Devidas M, Hunger SP, Teachey DT, Raetz EA, Loh ML. Gupta S, et al. N Engl J Med. 2025 Feb 27;392(9):875-891. doi: 10.1056/NEJMoa2411680. Epub 2024 Dec 7. N Engl J Med. 2025. PMID: 39651791 Free PMC article. Clinical Trial.
Molecular characterization informs prognosis in patients with localized Ewing sarcoma: A report from the Children's Oncology Group.
Gillani R, Shulman DS, DelRocco NJ, Klega K, Han R, Krailo MD, Slack JC, Tanhaemami M, Ward A, Bainer V, Ricker C, Sparks J, Bailey KM, Reed DR, DuBois SG, Leavey P, Mascarenhas L, Grohar PJ, Church AJ, Crompton BD, Janeway KA. Gillani R, et al. medRxiv [Preprint]. 2025 Jan 20:2025.01.20.25320840. doi: 10.1101/2025.01.20.25320840. medRxiv. 2025. PMID: 39974064 Free PMC article. Preprint.
A multiomic atlas identifies a treatment-resistant, bone marrow progenitor-like cell population in T cell acute lymphoblastic leukemia.
Xu J, Chen C, Sussman JH, Yoshimura S, Vincent T, Pölönen P, Hu J, Bandyopadhyay S, Elghawy O, Yu W, Tumulty J, Chen CH, Li EY, Diorio C, Shraim R, Newman H, Uppuluri L, Li A, Chen GM, Wu DW, Ding YY, Xu JA, Karanfilovski D, Lim T, Hsu M, Thadi A, Ahn KJ, Wu CY, Peng J, Sun Y, Wang A, Mehta R, Frank D, Meyer L, Loh ML, Raetz EA, Chen Z, Wood BL, Devidas M, Dunsmore KP, Winter SS, Chang TC, Wu G, Pounds SB, Zhang NR, Carroll W, Hunger SP, Bernt K, Yang JJ, Mullighan CG, Tan K, Teachey DT. Xu J, et al. Nat Cancer. 2025 Jan;6(1):102-122. doi: 10.1038/s43018-024-00863-5. Epub 2024 Nov 25. Nat Cancer. 2025. PMID: 39587259 Free PMC article.
Impact of the COVID-19 Pandemic Onset on the Early Careers of Pediatric Oncology Health Professionals and Researchers: A Report From the Children's Oncology Group Young Investigators Committee, Young SIOP Network, and Young SIOPE.
Bryan G, Guolla L, Villanueva GI, Cohen-Gogo S, Casanovas A, Medina R, Revon-Riviere G, Coltin H, Kahalley LS, Withycombe JS, van Ewijk R, Schoot RA, Cash T, Baertschiger RM, McAleer MF, Benedetti DJ, Greengard E, Kitko CL, Green AL, Dhall G, Esbenshade AJ. Bryan G, et al. Pediatr Blood Cancer. 2025 Jan;72(1):e31419. doi: 10.1002/pbc.31419. Epub 2024 Nov 6. Pediatr Blood Cancer. 2025. PMID: 39502016
Outcomes of patients with intermediate-risk neuroblastoma presenting with motor deficits relating to intraspinal tumor extension: A report from the Children's Oncology Group study ANBL0531.
Voeller J, Katzenstein HM, Naranjo A, Tenney SC, Chen L, London WB, Handler MH, Schmidt ML, Shimada H, Hogarty MD, Gastier-Foster J, Park JR, Cohn SL, Maris JM, Bagatell R, Twist CJ. Voeller J, et al. Pediatr Blood Cancer. 2025 Jan;72(1):e31407. doi: 10.1002/pbc.31407. Epub 2024 Nov 6. Pediatr Blood Cancer. 2025. PMID: 39502014
Evaluation of Image-Defined Risk Factor (IDRF) Assessment in Patients With Intermediate-risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531.
Brown EG, Adkins ES, Mattei P, Hoffer FA, Wootton-Gorges SL, London WB, Naranjo A, Schmidt ML, Hogarty MD, Irwin MS, Cohn SL, Park JR, Maris JM, Bagatell R, Twist CJ, Nuchtern JG, Davidoff AM, Newman EA, Lal DR. Brown EG, et al. J Pediatr Surg. 2025 Jan;60(1):161896. doi: 10.1016/j.jpedsurg.2024.161896. Epub 2024 Sep 6. J Pediatr Surg. 2025. PMID: 39317567 Free article.
Optimizing Ewing Sarcoma and Osteosarcoma Biopsy Acquisition: A Children's Oncology Group Bone Tumor Committee Consensus Statement.
Dietz MS, Al-Ibraheemi A, Davis JL, Hawkins CM, Craig BT, Dasgupta R, Geller DS, Shulman DS, Cohen-Gogo S, Gupta A, Whiteway SL, Slotkin EK, Heske CM, Ahmed SK, Indelicato DJ, Albert CM, Montgomery N, Sandberg JK, Grier HE, Krailo M, Isakoff MS, Rubin E, Lawlor ER, DuBois SG, Mascarenhas L, Grohar PJ, Binitie O, Reed D, Janeway K, Roberts RD, Bailey KM. Dietz MS, et al. J Natl Compr Canc Netw. 2024 Dec 27;23(1):e247063. doi: 10.6004/jnccn.2024.7063. J Natl Compr Canc Netw. 2024. PMID: 39729709 Free PMC article.
Long-read epigenomic diagnosis and prognosis of Acute Myeloid Leukemia.
Lamba J, Marchi F, Landwehr M, Schade AK, Shastri V, Ghavami M, Sckaff F, Marrero R, Nguyen N, Mansinghka V, Cao X, Slayton W, Starostik P, Ribeiro R, Rubnitz J, Klco J, Gamis A, Triche T Jr, Ries R, Kolb EA, Aplenc R, Alonzo T, Pounds S, Meshinchi S, Cogle C, Elsayed A. Lamba J, et al. Res Sq [Preprint]. 2024 Dec 12:rs.3.rs-5450972. doi: 10.21203/rs.3.rs-5450972/v1. Res Sq. 2024. Update in: Nat Commun. 2025 Jul 29;16(1):6961. doi: 10.1038/s41467-025-62005-4. PMID: 39711573 Free PMC article. Updated. Preprint.
Feasibility of a prospective pediatric melanocytic tumor clinical trial: A report of multidisciplinary clinician survey data from the Children's Oncology Group Rare Tumor Committee.
Mitchell SG, Christison-Lagay E, Aldrink J, Sargen MR, Laetsch TW, Austin M, Jen M, Gartrell R, Karunamurthy A, Kirkwood JM, Pappo AS, Seynnaeve BKN. Mitchell SG, et al. Pediatr Blood Cancer. 2024 Dec;71(12):e31312. doi: 10.1002/pbc.31312. Epub 2024 Sep 9. Pediatr Blood Cancer. 2024. PMID: 39252525 No abstract available.
Azacitidine as epigenetic priming for chemotherapy is safe and well-tolerated in infants with newly diagnosed KMT2A-rearranged acute lymphoblastic leukemia: Children's Oncology Group trial AALL15P1.
Guest EM, Kairalla JA, Devidas M, Hibbitts E, Carroll AJ, Heerema NA, Kubaney HR, August MA, Ramesh S, Yoo B, Farooqi MS, Pauly MG, Wechsler DS, Miles RR, Reid JM, Kihei CD, Gore L, Raetz EA, Hunger SP, Loh ML, Brown PA. Guest EM, et al. Haematologica. 2024 Dec 1;109(12):3918-3927. doi: 10.3324/haematol.2024.285158. Haematologica. 2024. PMID: 38867582 Free PMC article. Clinical Trial.
Long-term outcomes and patterns of relapse in patients with bilateral Wilms tumor or bilaterally predisposed unilateral Wilms tumor, a report from the COG AREN0534 study.
Murphy AJ, Brzezinski J, Renfro LA, Tornwall B, Malek MM, Benedetti DJ, Cost NG, Smith EA, Aldrink J, Romao RLP, Dome JS, Davidoff AM, Treece AL, Parsons LN, Mullen EA, Shamberger RC, Paulino AC, Lo AC, Geller JI, Ehrlich PF. Murphy AJ, et al. Int J Cancer. 2024 Nov 15;155(10):1824-1831. doi: 10.1002/ijc.35080. Epub 2024 Jul 8. Int J Cancer. 2024. PMID: 38973574 Clinical Trial.
Roadmap for the next generation of Children's Oncology Group rhabdomyosarcoma trials.
Metts JL, Aye JM, Crane JN, Oberoi S, Balis FM, Bhatia S, Bona K, Carleton B, Dasgupta R, Dela Cruz FS, Greenzang KA, Kaufman JL, Linardic CM, Parsons SK, Robertson-Tessi M, Rudzinski ER, Soragni A, Stewart E, Weigel BJ, Wolden SL, Weiss AR, Venkatramani R, Heske CM. Metts JL, et al. Cancer. 2024 Nov 15;130(22):3785-3796. doi: 10.1002/cncr.35457. Epub 2024 Jun 28. Cancer. 2024. PMID: 38941509
Heterogeneity of IKZF1 genomic alterations and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia.
Mullighan C, Wangondu R, Ashcraft E, Chang TC, Roberts K, Brady S, Fan Y, Evans W, Relling M, Crews K, Yang J, Yang W, Pounds S, Wu G, Devidas M, Maloney K, Mattano L Jr, Schore R, Angiolillo A, Larsen E, Salzer W, Burke M, Loh M, Jeha S, Pui CH, Inaba H, Cheng C. Mullighan C, et al. Res Sq [Preprint]. 2024 Nov 11:rs.3.rs-5292018. doi: 10.21203/rs.3.rs-5292018/v1. Res Sq. 2024. Update in: Leukemia. 2025 Jul;39(7):1595-1606. doi: 10.1038/s41375-025-02633-3. PMID: 39606455 Free PMC article. Updated. Preprint.
Artificial intelligence-based morphologic classification and molecular characterization of neuroblastic tumors from digital histopathology.
Ramesh S, Dyer E, Pomaville M, Doytcheva K, Dolezal J, Kochanny S, Terhaar R, Mehrhoff CJ, Patel K, Brewer J, Kusswurm B, Naranjo A, Shimada H, Cipriani NA, Husain AN, Pytel P, Sokol EA, Cohn SL, George RE, Pearson AT, Applebaum MA. Ramesh S, et al. NPJ Precis Oncol. 2024 Nov 8;8(1):255. doi: 10.1038/s41698-024-00745-0. NPJ Precis Oncol. 2024. PMID: 39511421 Free PMC article.
Determinants of survival after first relapse of acute lymphoblastic leukemia: a Children's Oncology Group study.
Rheingold SR, Bhojwani D, Ji L, Xu X, Devidas M, Kairalla JA, Shago M, Heerema NA, Carroll AJ, Breidenbach H, Borowitz M, Wood BL, Angiolillo AL, Asselin BL, Bowman WP, Brown P, Dreyer ZE, Dunsmore KP, Hilden JM, Larsen E, Maloney K, Matloub Y, Mattano LA, Winter SS, Gore L, Winick NJ, Carroll WL, Hunger SP, Raetz EA, Loh ML. Rheingold SR, et al. Leukemia. 2024 Nov;38(11):2382-2394. doi: 10.1038/s41375-024-02395-4. Epub 2024 Sep 11. Leukemia. 2024. PMID: 39261601 Free PMC article.
Multilevel challenges to equitable inclusion of children in trials when parents use languages other than English: A qualitative report from Children's Oncology Group's Diversity and Health Disparities Committee Language Equity Working Group.
Santacroce SJ, Beauchemin MP, Pelletier W, Robles JM, Ruiz J, Blazin LJ, Aristizabal P, Orjuela-Grimm M, Hall AG, Kahn J, Kline C, Seif AE, Velez MC, Winestone LE. Santacroce SJ, et al. Pediatr Blood Cancer. 2024 Nov;71(11):e31321. doi: 10.1002/pbc.31321. Epub 2024 Sep 5. Pediatr Blood Cancer. 2024. PMID: 39238140 Free PMC article.
Genomic Determinants of Outcome in Acute Lymphoblastic Leukemia.
Chang TC, Chen W, Qu C, Cheng Z, Hedges D, Elsayed A, Pounds SB, Shago M, Rabin KR, Raetz EA, Devidas M, Cheng C, Angiolillo A, Baviskar P, Borowitz M, Burke MJ, Carroll A, Carroll WL, Chen IM, Harvey R, Heerema N, Iacobucci I, Wang JR, Jeha S, Larsen E, Mattano L, Maloney K, Pui CH, Ramirez NC, Salzer W, Willman C, Winick N, Wood B, Hunger SP, Wu G, Mullighan CG, Loh ML. Chang TC, et al. J Clin Oncol. 2024 Oct 10;42(29):3491-3503. doi: 10.1200/JCO.23.02238. Epub 2024 Aug 9. J Clin Oncol. 2024. PMID: 39121442 Free PMC article.
Reply to C.T. Matava et al.
Alexander S, Kairalla JA, Gupta S, Hibbitts E, Weisman H, Anghelescu D, Winick NJ, Krull KR, Salzer WL, Burke MJ, Gore L, Devidas M, Embry L, Raetz EA, Hunger SP, Loh ML, Hardy KK. Alexander S, et al. J Clin Oncol. 2024 Oct 10;42(29):3507-3509. doi: 10.1200/JCO-24-01244. Epub 2024 Jul 24. J Clin Oncol. 2024. PMID: 39047217 Free PMC article. No abstract available.
Design and methods of the StepByStep randomized trial of a mobile health and social media physical activity intervention among adolescent and young adult survivors of childhood cancer: A report from the Children's Oncology Group.
Beight LJ, Mendoza JA, Leisenring WM, Collier W, Olsen ME, Ross WL, Santiago-Rivera Y, Bryant S, Rotatori J, Ness KK, Hurtado-de-Mendoza A, Baker KS, Chow EJ, Kadan-Lottick NS. Beight LJ, et al. Contemp Clin Trials. 2024 Oct;145:107645. doi: 10.1016/j.cct.2024.107645. Epub 2024 Jul 28. Contemp Clin Trials. 2024. PMID: 39079612 Free PMC article.
A subset of image-defined risk factors predict completeness of resection in children with high-risk neuroblastoma: An international multicenter study.
Espinoza AF, Bagatell R, McHugh K, Naranjo AH, Van Ryn C, Rojas Y, Lyons K, Guillerman RP, Kirby C, Brock P, Volchenboum S, Simon T, States L, Miller A, Krug B, Sarnacki S, Irtan S, Brisse HJ, Valteau-Couanet D, von Schweinitz D, Kammer B, Granata C, Pio L, Park JR, Nuchtern JG. Espinoza AF, et al. Pediatr Blood Cancer. 2024 Oct;71(10):e31218. doi: 10.1002/pbc.31218. Epub 2024 Jul 28. Pediatr Blood Cancer. 2024. PMID: 39072986 Free PMC article.
Healthcare utilization disparities among children with high-risk neuroblastoma treated on Children's Oncology Group clinical trials.
Shoag J, Li Y, Getz KD, Huang YS, Hall M, Naranjo A, Richardson T, Desai AV, Umaretiya PJ, Aziz-Bose R, Kelly CA, Zheng DJ, Newman H, Zahler S, Aplenc R, Bagatell R, Bona K. Shoag J, et al. Pediatr Blood Cancer. 2024 Oct;71(10):e31192. doi: 10.1002/pbc.31192. Epub 2024 Jul 12. Pediatr Blood Cancer. 2024. PMID: 38997807 Free PMC article.
Clinical Practice Guideline-Inconsistent Management of Fertility Preservation in Pediatric Cancer Patients in Community Settings: A Children's Oncology Group Study.
Grimes AC, Sugalski AJ, Nuño MM, Ramakrishnan S, Beauchemin MP, Robinson PD, Santesso N, Walsh AM, Wrightson AR, Yu LC, Parsons SK, Sung L, Dupuis LL. Grimes AC, et al. J Adolesc Young Adult Oncol. 2024 Oct;13(5):776-784. doi: 10.1089/jayao.2024.0022. Epub 2024 May 21. J Adolesc Young Adult Oncol. 2024. PMID: 38770790 Free PMC article.
Automatic Quantification of Serial PET/CT Images for Pediatric Hodgkin Lymphoma Patients Using a Longitudinally-Aware Segmentation Network.
Tie X, Shin M, Lee C, Perlman SB, Huemann Z, Weisman AJ, Castellino SM, Kelly KM, McCarten KM, Alazraki AL, Hu J, Cho SY, Bradshaw TJ. Tie X, et al. ArXiv [Preprint]. 2024 Oct 1:arXiv:2404.08611v2. ArXiv. 2024. Update in: Radiol Artif Intell. 2025 May;7(3):e240229. doi: 10.1148/ryai.240229. PMID: 38659641 Free PMC article. Updated. Preprint.
CD74 is expressed in a subset of pediatric acute myeloid leukemia patients and is a promising target for therapy: a report from the Children's Oncology Group.
Menssen AJ, Hudson CA, Alonzo T, Gerbing R, Pardo L, Leonti A, Cook JA, Hsu FC, Lott LL, Dai F, Fearing C, Ghirardelli K, Hylkema T, Tarlock K, Loeb KR, Kolb EA, Cooper T, Pollard J, Wells DA, Loken MR, Aplenc R, Meshinchi S, Brodersen LE. Menssen AJ, et al. Haematologica. 2024 Oct 1;109(10):3182-3193. doi: 10.3324/haematol.2023.283757. Haematologica. 2024. PMID: 38299667 Free PMC article.
Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children's Oncology Group.
Stieglitz E, Lee AG, Angus SP, Davis C, Barkauskas DA, Hall D, Kogan SC, Meyer J, Rhodes SD, Tasian SK, Xuei X, Shannon K, Loh ML, Fox E, Weigel BJ. Stieglitz E, et al. Cancer Discov. 2024 Sep 4;14(9):1590-1598. doi: 10.1158/2159-8290.CD-23-1376. Cancer Discov. 2024. PMID: 38867349 Free PMC article. Clinical Trial.
Palbociclib in Solid Tumor Patients With Genomic Alterations in the cyclinD-cdk4/6-INK4a-Rb Pathway: Results From National Cancer Institute-Children's Oncology Group Pediatric Molecular Analysis for Therapy Choice Trial Arm I (APEC1621I).
Macy ME, Mody R, Reid JM, Piao J, Saguilig L, Alonzo TA, Berg SL, Fox E, Weigel BJ, Hawkins DS, Mooney MM, Williams PM, Patton DR, Coffey BD, Roy-Chowdhuri S, Takebe N, Tricoli JV, Janeway KA, Seibel NL, Parsons DW. Macy ME, et al. JCO Precis Oncol. 2024 Sep;8:e2400418. doi: 10.1200/PO-24-00418. JCO Precis Oncol. 2024. PMID: 39298716 Free PMC article. Clinical Trial.
Phase II Study of Samotolisib in Children and Young Adults With Tumors Harboring Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Pathway Alterations: Pediatric MATCH APEC1621D.
Laetsch TW, Ludwig K, Williams PM, Roy-Chowdhuri S, Patton DR, Coffey B, Reid JM, Piao J, Saguilig L, Alonzo TA, Berg SL, Mhlanga J, Fox E, Weigel BJ, Hawkins DS, Mooney MM, Takebe N, Tricoli JV, Janeway KA, Seibel NL, Parsons DW. Laetsch TW, et al. JCO Precis Oncol. 2024 Sep;8:e2400258. doi: 10.1200/PO.24.00258. JCO Precis Oncol. 2024. PMID: 39298693 Free PMC article. Clinical Trial.
Impact of age on safety of Busulfan-Melphalan followed by autologous hematopoietic stem-cell transplantation versus standard chemotherapy in the patients of the EURO-E.W.I.N.G. 99 and Ewing 2008 clinical trials.
Choderlos de Laclos X, Risbourg S, Brennan B, Bertucci F, Gaspar N, Gelderblom H, Hawkins DS, Janeway K, Juergens H, Kasper B, Krailo MD, Cécile Le Deley M, Marec-Bérard P, McCabe MG, Metzler M, Ranft A, Strauss S, Tabone MD, Windsor R, Dirksen U, Gandemer V. Choderlos de Laclos X, et al. Eur J Cancer. 2024 Sep;208:114229. doi: 10.1016/j.ejca.2024.114229. Epub 2024 Jul 15. Eur J Cancer. 2024. PMID: 39032218 Free PMC article. Clinical Trial.
Impact of Genetic Ancestry on T-cell Acute Lymphoblastic Leukemia Outcomes.
Teachey D, Newman H, Lee S, Pölönen P, Shraim R, Li Y, Liu H, Aplenc R, Bandyopadhyay S, Chen C, Chen Z, Devidas M, Diorio C, Dunsmore K, Elghawy O, Elhachimi A, Fuller T, Gupta S, Hall J, Hughes A, Hunger S, Loh M, Martinez Z, McCoy M, Mullen C, Pounds S, Raetz E, Ryan T, Seffernick A, Shi G, Sussman J, Tan K, Uppuluri L, Vincent TL, Wang'ondu R, Winestone L, Winter S, Wood B, Wu G, Xu J, Yang W, Mullighan C, Yang J, Bona K. Teachey D, et al. Res Sq [Preprint]. 2024 Aug 16:rs.3.rs-4858231. doi: 10.21203/rs.3.rs-4858231/v1. Res Sq. 2024. Update in: Blood Cancer Discov. 2025 May 28. doi: 10.1158/2643-3230.BCD-25-0049. PMID: 39184069 Free PMC article. Updated. Preprint.
Phase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm G.
Nelson MV, Kim A, Williams PM, Roy-Chowdhuri S, Patton DR, Coffey BD, Reid JM, Piao J, Saguilig L, Alonzo TA, Berg SL, Ramirez NC, Jaju A, Fox E, Weigel BJ, Hawkins DS, Mooney MM, Takebe N, Tricoli JV, Janeway KA, Seibel NL, Parsons DW. Nelson MV, et al. Oncologist. 2024 Aug 5;29(8):723-e1093. doi: 10.1093/oncolo/oyae119. Oncologist. 2024. PMID: 38873934 Free PMC article. Clinical Trial.
The genomic basis of childhood T-lineage acute lymphoblastic leukaemia.
Pölönen P, Di Giacomo D, Seffernick AE, Elsayed A, Kimura S, Benini F, Montefiori LE, Wood BL, Xu J, Chen C, Cheng Z, Newman H, Myers J, Iacobucci I, Li E, Sussman J, Hedges D, Hui Y, Diorio C, Uppuluri L, Frank D, Fan Y, Chang Y, Meshinchi S, Ries R, Shraim R, Li A, Bernt KM, Devidas M, Winter SS, Dunsmore KP, Inaba H, Carroll WL, Ramirez NC, Phillips AH, Kriwacki RW, Yang JJ, Vincent TL, Zhao Y, Ghate PS, Wang J, Reilly C, Zhou X, Sanders MA, Takita J, Kato M, Takasugi N, Chang BH, Press RD, Loh M, Rampersaud E, Raetz E, Hunger SP, Tan K, Chang TC, Wu G, Pounds SB, Mullighan CG, Teachey DT. Pölönen P, et al. Nature. 2024 Aug;632(8027):1082-1091. doi: 10.1038/s41586-024-07807-0. Epub 2024 Aug 14. Nature. 2024. PMID: 39143224 Free PMC article.
Integrated drug resistance and leukemic stemness gene-expression scores predict outcomes in large cohort of over 3500 AML patients from 10 trials.
H Elsayed A, Cao X, Marrero RJ, Nguyen NHK, Wu H, Ni Y, Ribeiro RC, Tobias H, Valk PJ, Béliveau F, Richard-Carpentier G, Hébert J, Zwaan CM, Gamis A, Kolb EA, Aplenc R, Alonzo TA, Meshinchi S, Rubnitz J, Pounds S, Lamba JK. H Elsayed A, et al. NPJ Precis Oncol. 2024 Aug 1;8(1):168. doi: 10.1038/s41698-024-00643-5. NPJ Precis Oncol. 2024. PMID: 39090192 Free PMC article.
Long-term follow-up of patients with intermediate-risk neuroblastoma treated with response- and biology-based therapy: A report from the Children's Oncology Group study ANBL0531.
Barr EK, Naranjo A, Twist CJ, Tenney SC, Schmidt ML, London WB, Gastier-Foster J, Adkins ES, Mattei P, Handler MH, Matthay KK, Park JR, Maris JM, Desai AV, Cohn SL. Barr EK, et al. Pediatr Blood Cancer. 2024 Aug;71(8):e31089. doi: 10.1002/pbc.31089. Epub 2024 May 31. Pediatr Blood Cancer. 2024. PMID: 38822537 Free PMC article.
Exposure-Response and Subgroup Analyses to Support Body Weight-Based Dosing of Brentuximab Vedotin in Children and Young Adults with Newly Diagnosed High-risk Classical Hodgkin Lymphoma.
Zhang Z, Zhang D, Guo W, Fenton K, Narayanan S, Jain S, Jiang J, Castellino SM, Kelly KM, Cole PD, Keller FG, Garg A, Chia YL. Zhang Z, et al. Clin Cancer Res. 2024 Aug 1;30(15):3273-3281. doi: 10.1158/1078-0432.CCR-23-3655. Clin Cancer Res. 2024. PMID: 38810021 Free PMC article. Clinical Trial.
Clinical features and outcomes of young patients with low-grade non-rhabdomyosarcoma soft tissue sarcomas treated with a risk-based strategy: A report from Children's Oncology Group study ARST0332.
Douglass DP, Coffin CM, Randall RL, Yang Y, Barkauskas DA, Million L, McCarville MB, Pappo AS, Weiss AR, Spunt SL. Douglass DP, et al. Pediatr Blood Cancer. 2024 Aug;71(8):e31062. doi: 10.1002/pbc.31062. Epub 2024 May 16. Pediatr Blood Cancer. 2024. PMID: 38757485 Free PMC article.
Impact of Propofol Exposure on Neurocognitive Outcomes in Children With High-Risk B ALL: A Children's Oncology Group Study.
Alexander S, Kairalla JA, Gupta S, Hibbitts E, Weisman H, Anghelescu D, Winick NJ, Krull KR, Salzer WL, Burke MJ, Gore L, Devidas M, Embry L, Raetz EA, Hunger SP, Loh ML, Hardy KK. Alexander S, et al. J Clin Oncol. 2024 Aug 1;42(22):2671-2679. doi: 10.1200/JCO.23.01989. Epub 2024 Apr 11. J Clin Oncol. 2024. PMID: 38603641 Free PMC article. Clinical Trial.
Olaparib for childhood tumors harboring defects in DNA damage repair genes: arm H of the NCI-COG Pediatric MATCH trial.
Glade Bender JL, Pinkney K, Williams PM, Roy-Chowdhuri S, Patton DR, Coffey BD, Reid JM, Piao J, Saguilig L, Alonzo TA, Berg SL, Ramirez NC, Fox E, Weigel BJ, Hawkins DS, Mooney MM, Takebe N, Tricoli JV, Janeway KA, Seibel NL, Parsons DW. Glade Bender JL, et al. Oncologist. 2024 Jul 5;29(7):638-e952. doi: 10.1093/oncolo/oyae096. Oncologist. 2024. PMID: 38815151 Free PMC article. Clinical Trial.
Addition of temsirolimus to chemotherapy in children, adolescents, and young adults with intermediate-risk rhabdomyosarcoma (ARST1431): a randomised, open-label, phase 3 trial from the Children's Oncology Group.
Gupta AA, Xue W, Harrison DJ, Hawkins DS, Dasgupta R, Wolden S, Shulkin B, Qumseya A, Routh JC, MacDonald T, Feinberg S, Crompton B, Rudzinski ER, Arnold M, Venkatramani R. Gupta AA, et al. Lancet Oncol. 2024 Jul;25(7):912-921. doi: 10.1016/S1470-2045(24)00255-9. Lancet Oncol. 2024. PMID: 38936378 Free PMC article. Clinical Trial.
Clinical trial recruitment of people who speak languages other than English: a Children's Oncology Group report.
Beauchemin MP, Ortega M, Santacroce SJ, Robles JM, Ruiz J, Hall AG, Kahn JM, Fu C, Orjuela-Grimm M, Hillyer GC, Solomon S, Pelletier W, Montiel-Esparza R, Blazin LJ, Kline C, Seif AE, Aristizabal P, Winestone LE, Velez MC. Beauchemin MP, et al. JNCI Cancer Spectr. 2024 Jul 1;8(4):pkae047. doi: 10.1093/jncics/pkae047. JNCI Cancer Spectr. 2024. PMID: 38889291 Free PMC article.
Bilateral Wilms tumor with anaplasia: A report from the Children's Oncology Group Study AREN0534.
Romao RLP, Aldrink JH, Renfro LA, Mullen EA, Murphy AJ, Brzezinski J, Malek MM, Benedetti DJ, Cost NG, Smith E, Dome JS, Davidoff AM, Treece A, Parsons LN, Fernandez CV, Tornwall B, Shamberger RC, Paulino A, Kalapurakal JA, Geller JI, Ehrlich PF. Romao RLP, et al. Pediatr Blood Cancer. 2024 Jul;71(7):e30981. doi: 10.1002/pbc.30981. Epub 2024 Apr 18. Pediatr Blood Cancer. 2024. PMID: 38637871 Free PMC article.
Treatment and outcomes of clear cell sarcoma of the kidney: A report from the Children's Oncology Group studies AREN0321 and AREN03B2.
Benedetti DJ, Renfro LA, Tfirn I, Daw NC, Kalapurakal JA, Ehrlich PF, Khanna G, Perlman E, Warwick A, Gow KW, Paulino AC, Seibel NL, Grundy P, Fernandez CV, Geller JI, Mullen EA, Dome JS. Benedetti DJ, et al. Cancer. 2024 Jul 1;130(13):2361-2371. doi: 10.1002/cncr.35266. Epub 2024 Feb 23. Cancer. 2024. PMID: 38396300 Free PMC article. Clinical Trial.
Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia.
van Weelderen RE, Harrison CJ, Klein K, Jiang Y, Abrahamsson J, Alonzo T, Aplenc R, Arad-Cohen N, Bart-Delabesse E, Buldini B, De Moerloose B, Dworzak MN, Elitzur S, Fernández Navarro JM, Gamis A, Gerbing RB, Goemans BF, de Groot-Kruseman HA, Guest E, Ha SY, Hasle H, Kelaidi C, Lapillonne H, Leverger G, Locatelli F, Miyamura T, Norén-Nyström U, Polychronopoulou S, Rasche M, Rubnitz JE, Stary J, Tierens A, Tomizawa D, Zwaan CM, Kaspers GJL. van Weelderen RE, et al. Blood Adv. 2024 Jun 25;8(12):3200-3213. doi: 10.1182/bloodadvances.2023011771. Blood Adv. 2024. PMID: 38621200 Free PMC article.
Artificial intelligence-based morphologic classification and molecular characterization of neuroblastic tumors from digital histopathology.
Applebaum M, Ramesh S, Dyer E, Pomaville M, Doytcheva K, Dolezal J, Kochanny S, Terhaar R, Mehrhoff C, Patel K, Brewer J, Kusswurm B, Naranjo A, Shimada H, Sokol E, Cohn S, George R, Pearson A. Applebaum M, et al. Res Sq [Preprint]. 2024 Jun 4:rs.3.rs-4396782. doi: 10.21203/rs.3.rs-4396782/v1. Res Sq. 2024. Update in: NPJ Precis Oncol. 2024 Nov 8;8(1):255. doi: 10.1038/s41698-024-00745-0. PMID: 38883758 Free PMC article. Updated. Preprint.
Phase II Study of Ulixertinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Alterations: APEC1621J of the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial.
Vo KT, Sabnis AJ, Williams PM, Roy-Chowdhuri S, Patton DR, Coffey B, Reid JM, Piao J, Saguilig L, Alonzo TA, Berg SL, Jaju A, Fox E, Weigel BJ, Hawkins DS, Mooney MM, Takebe N, Tricoli JV, Janeway KA, Seibel NL, Parsons DW. Vo KT, et al. JCO Precis Oncol. 2024 Jun;8:e2400103. doi: 10.1200/PO.24.00103. JCO Precis Oncol. 2024. PMID: 38935895 Free PMC article. Clinical Trial.
MRD at the end of induction and EFS in T-cell lymphoblastic lymphoma: Children's Oncology Group trial AALL1231.
Hayashi RJ, Hermiston ML, Wood BL, Teachey DT, Devidas M, Chen Z, Annett RD, Asselin BL, August K, Cho S, Dunsmore KP, Freedman JL, Galardy PJ, Harker-Murray P, Horton TM, Jaju A, Lam A, Messinger YH, Miles RR, Okada M, Patel S, Schafer ES, Schechter T, Shimano KA, Singh N, Steele A, Sulis ML, Vargas SL, Winter SS, Wood C, Zweidler-McKay PA, Loh ML, Hunger SP, Raetz EA, Bollard CM, Allen CE. Hayashi RJ, et al. Blood. 2024 May 16;143(20):2053-2058. doi: 10.1182/blood.2023021184. Blood. 2024. PMID: 38457359 Free PMC article. Clinical Trial.
Prognostic impact of cooccurring mutations in FLT3-ITD pediatric acute myeloid leukemia.
Tarlock K, Gerbing RB, Ries RE, Smith JL, Leonti A, Huang BJ, Kirkey D, Robinson L, Peplinski JH, Lange B, Cooper TM, Gamis AS, Kolb EA, Aplenc R, Pollard JA, Alonzo TA, Meshinchi S. Tarlock K, et al. Blood Adv. 2024 May 14;8(9):2094-2103. doi: 10.1182/bloodadvances.2023011980. Blood Adv. 2024. PMID: 38295280 Free PMC article.
Rare germline structural variants increase risk for pediatric solid tumors.
Gillani R, Collins RL, Crowdis J, Garza A, Jones JK, Walker M, Sanchis-Juan A, Whelan C, Pierce-Hoffman E, Talkowski M, Brand H, Haigis K, LoPiccolo J, AlDubayan SH, Gusev A, Crompton BD, Janeway KA, Van Allen EM. Gillani R, et al. bioRxiv [Preprint]. 2024 Apr 29:2024.04.27.591484. doi: 10.1101/2024.04.27.591484. bioRxiv. 2024. Update in: Science. 2025 Jan 3;387(6729):eadq0071. doi: 10.1126/science.adq0071. PMID: 38746320 Free PMC article. Updated. Preprint.
Chromatin Profiles Are Prognostic of Clinical Response to Bortezomib-Containing Chemotherapy in Pediatric Acute Myeloid Leukemia: Results from the COG AAML1031 Trial.
van Dijk AD, Hoff FW, Qiu Y, Hubner SE, Go RL, Ruvolo VR, Leonti AR, Gerbing RB, Gamis AS, Aplenc R, Kolb EA, Alonzo TA, Meshinchi S, de Bont ESJM, Horton TM, Kornblau SM. van Dijk AD, et al. Cancers (Basel). 2024 Apr 9;16(8):1448. doi: 10.3390/cancers16081448. Cancers (Basel). 2024. PMID: 38672531 Free PMC article.
Enhanced Risk Stratification for Children and Young Adults with B-Cell Acute Lymphoblastic Leukemia: A Children's Oncology Group Report.
DelRocco NJ, Loh ML, Borowitz MJ, Gupta S, Rabin KR, Zweidler-McKay P, Maloney KW, Mattano LA, Larsen E, Angiolillo A, Schore RJ, Burke MJ, Salzer WL, Wood BL, Carroll AJ, Heerema NA, Reshmi SC, Gastier-Foster JM, Harvey R, Chen IM, Roberts KG, Mullighan CG, Willman C, Winick N, Carroll WL, Rau RE, Teachey DT, Hunger SP, Raetz EA, Devidas M, Kairalla JA. DelRocco NJ, et al. Leukemia. 2024 Apr;38(4):720-728. doi: 10.1038/s41375-024-02166-1. Epub 2024 Feb 15. Leukemia. 2024. PMID: 38360863 Free PMC article.
Characteristics of Health Care Settings Where Adolescents and Young Adults Receive Care for ALL.
Wolfson JA, Grimes AC, Nuno M, Kerber CL, Ramakrishnan S, Beauchemin M, Dickens D, Levine JM, Roth ME, Scialla M, Woods W, Vargas S, Boayue KB, Chang GJ, Stock W, Hershman D, Curran E, Advani A, O'Dwyer K, Luger S, Liu JJ, Freyer DR, Sung L, Parsons SK. Wolfson JA, et al. JCO Oncol Pract. 2024 Apr;20(4):491-502. doi: 10.1200/OP.23.00328. Epub 2024 Jan 22. JCO Oncol Pract. 2024. PMID: 38252911 Free PMC article.
Race and Ethnic Group Enrollment and Outcomes for Wilms Tumor: Analysis of the Current Era Children's Oncology Group Study, AREN03B2.
Lovvorn HN 3rd, Renfro LA, Benedetti DJ, Kotagal M, Phelps HM, Ehrlich PF, Lo AC, Sandberg JK, Treece AL, Gow KW, Glick RD, Davidoff AM, Cost NG, Dix DB, Fernandez CV, Dome JS, Geller JI, Mullen EA. Lovvorn HN 3rd, et al. J Am Coll Surg. 2024 Apr 1;238(4):733-749. doi: 10.1097/XCS.0000000000000999. Epub 2024 Mar 15. J Am Coll Surg. 2024. PMID: 38251681 Free PMC article.
Treatment of children with favorable histology Wilms tumor with extrapulmonary metastases: A report from the COG studies AREN0533 and AREN03B2 and NWTSG study NWTS-5.
Benedetti DJ, Varela CR, Renfro LA, Tornwall B, Dix DB, Ehrlich PF, Glick RD, Kalapurakal J, Perlman E, Gratias E, Seibel NL, Geller JI, Khanna G, Malogolowkin M, Grundy P, Fernandez CV, Dome JS, Mullen EA. Benedetti DJ, et al. Cancer. 2024 Mar 15;130(6):947-961. doi: 10.1002/cncr.35099. Epub 2023 Nov 7. Cancer. 2024. PMID: 37933882 Free PMC article. Clinical Trial.
Vorinostat, temozolomide or bevacizumab with irradiation and maintenance BEV/TMZ in pediatric high-grade glioma: A Children's Oncology Group Study.
Lulla RR, Buxton A, Krailo MD, Lazow MA, Boue DR, Leach JL, Lin T, Geller JI, Kumar SS, Nikiforova MN, Chandran U, Jogal SS, Nelson MD Jr, Onar-Thomas A, Haas-Kogan DA, Cohen KJ, Kieran MW, Gajjar A, Drissi R, Pollack IF, Fouladi M. Lulla RR, et al. Neurooncol Adv. 2024 Mar 14;6(1):vdae035. doi: 10.1093/noajnl/vdae035. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 38596718 Free PMC article.
Germline Genetic Testing and Survival Outcomes Among Children With Rhabdomyosarcoma: A Report From the Children's Oncology Group.
Martin-Giacalone BA, Li H, Scheurer ME, Casey DL, Dugan-Perez S, Marquez-Do DA, Muzny D, Gibbs RA, Barkauskas DA, Hall D, Stewart DR, Schiffman JD, McEvoy MT, Khan J, Malkin D, Linardic CM, Crompton BD, Shern JF, Skapek SX, Venkatramani R, Hawkins DS, Sabo A, Plon SE, Lupo PJ. Martin-Giacalone BA, et al. JAMA Netw Open. 2024 Mar 4;7(3):e244170. doi: 10.1001/jamanetworkopen.2024.4170. JAMA Netw Open. 2024. PMID: 38546643 Free PMC article.
Evidence-Based Recommendations for Education Provided to Patients and Families Regarding the Adverse Events of ALK and MEK Inhibitors: A Systematic Review From the Children's Oncology Group.
Fisher B, Meyer A, Brown A, Conway Keller M, McKeown T, Tiller J, Saylor KM, Duffy EA. Fisher B, et al. J Pediatr Hematol Oncol Nurs. 2024 Mar-Apr;41(2):114-128. doi: 10.1177/27527530231206101. Epub 2024 Mar 28. J Pediatr Hematol Oncol Nurs. 2024. PMID: 38549368 Free PMC article.
Children's Oncology Group's 2023 blueprint for research: Surgery.
Gow KW, Lautz TB, Malek MM, Cost NG, Newman EA, Dasgupta R, Christison-Lagay ER, Tiao GM, Davidoff AM; COG Surgery Discipline Committee. Gow KW, et al. Pediatr Blood Cancer. 2024 Mar;71(3):e30766. doi: 10.1002/pbc.30766. Epub 2023 Nov 10. Pediatr Blood Cancer. 2024. PMID: 37950538 Free PMC article.
Prognostic impact of lymph node involvement and loss of heterozygosity of 1p or 16q in stage III favorable histology Wilms tumor: A report from Children's Oncology Group Studies AREN03B2 and AREN0532.
Evageliou N, Renfro LA, Geller J, Perlman E, Kalapurakal J, Paulino A, Dix D, Eklund MJ, Murphy AJ, Romao RLP, Ehrlich PF, Varela CR, Vallance K, Fernandez CV, Dome JS, Mullen EA. Evageliou N, et al. Cancer. 2024 Mar 1;130(5):792-802. doi: 10.1002/cncr.35084. Epub 2023 Oct 30. Cancer. 2024. PMID: 37902955 Free PMC article.
Addressing a Pre-Clinical Pipeline Gap: Development of the Pediatric Acute Myeloid Leukemia Patient-Derived Xenograft Program at Texas Children's Hospital at Baylor College of Medicine.
Stevens AM, Terrell M, Rashid R, Fisher KE, Marcogliese AN, Gaikwad A, Rao P, Vrana C, Krueger M, Loken M, Menssen AJ, Cook JA, Keogh N, Alozie M, Oviedo H, Gonzalez AK, Ilangovan T, Kim J, Sandhu S, Redell MS. Stevens AM, et al. Biomedicines. 2024 Feb 8;12(2):394. doi: 10.3390/biomedicines12020394. Biomedicines. 2024. PMID: 38397996 Free PMC article.
Effect of carvedilol versus placebo on cardiac function in anthracycline-exposed survivors of childhood cancer (PREVENT-HF): a randomised, controlled, phase 2b trial.
Armenian SH, Hudson MM, Lindenfeld L, Chen S, Chow EJ, Colan S, Collier W, Su X, Marcus E, Echevarria M, Iukuridze A, Robison LL, Wong FL, Chen MH, Bhatia S. Armenian SH, et al. Lancet Oncol. 2024 Feb;25(2):235-245. doi: 10.1016/S1470-2045(23)00637-X. Epub 2024 Jan 9. Lancet Oncol. 2024. PMID: 38215764 Free PMC article. Clinical Trial.
Outcomes in Children, Adolescents, and Young Adults With Down Syndrome and ALL: A Report From the Children's Oncology Group.
Rabin KR, Devidas M, Chen Z, Ji L, Kairalla J, Hitzler JK, Yang JJ, Carroll AJ, Heerema NA, Borowitz MJ, Wood BL, Roberts KG, Mullighan CG, Harvey RC, Chen IM, Willman CL, Reshmi SC, Gastier-Foster JM, Bhojwani D, Rheingold SR, Maloney KW, Mattano LA, Larsen EC, Schore RJ, Burke MJ, Salzer WL, Winick NJ, Carroll WL, Raetz EA, Loh ML, Hunger SP, Angiolillo AL. Rabin KR, et al. J Clin Oncol. 2024 Jan 10;42(2):218-227. doi: 10.1200/JCO.23.00389. Epub 2023 Oct 27. J Clin Oncol. 2024. PMID: 37890117 Free PMC article.
Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling.
Alig SK, Shahrokh Esfahani M, Garofalo A, Li MY, Rossi C, Flerlage T, Flerlage JE, Adams R, Binkley MS, Shukla N, Jin MC, Olsen M, Telenius A, Mutter JA, Schroers-Martin JG, Sworder BJ, Rai S, King DA, Schultz A, Bögeholz J, Su S, Kathuria KR, Liu CL, Kang X, Strohband MJ, Langfitt D, Pobre-Piza KF, Surman S, Tian F, Spina V, Tousseyn T, Buedts L, Hoppe R, Natkunam Y, Fornecker LM, Castellino SM, Advani R, Rossi D, Lynch R, Ghesquières H, Casasnovas O, Kurtz DM, Marks LJ, Link MP, André M, Vandenberghe P, Steidl C, Diehn M, Alizadeh AA. Alig SK, et al. Nature. 2024 Jan;625(7996):778-787. doi: 10.1038/s41586-023-06903-x. Epub 2023 Dec 11. Nature. 2024. PMID: 38081297 Free PMC article.
A multi-institutional feasibility study of intra-arterial chemotherapy in children with retinoblastoma. A Children's Oncology Group study (COG ARET12P1).
Chintagumpala M, Piao J, Gombos D, Chevez-Barrios P, Brock L, Dunkel IJ, Jubran R, Leahey AM, Kim J, O'Brien J, Shields CL, Rodriguez-Galindo C. Chintagumpala M, et al. Pediatr Blood Cancer. 2024 Jan;71(1):e30718. doi: 10.1002/pbc.30718. Epub 2023 Oct 10. Pediatr Blood Cancer. 2024. PMID: 37817345 Free PMC article.
1,104 results